Vismodegib identified as a novel COX-2 inhibitor via deep-learning-based drug repositioning and molecular docking analysis
Although the proposed treatment algorithm reflects the shared expert opinions and clinical experience of the authors, it is firmly grounded in current scientific evidence, synthesized through formal meta-analyses of all relevant randomized controlled trials that assess the effectiveness of obesity management medications, following rigorous methodological standards
[5] Related article: Experts Discuss: Do Weight Loss Drugs Like Ozempic Hold The Answer to Long-Term Weight Management
This is especially relevant for people with type 2 diabetes using tirzepatide in addition to existing diabetes medications
no soy, yeast, corn, wheat, sodium, salt, sugar, fat, cholesterol, color, preservative, common allergens or manufacturing additives